Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06795035 · ClinicalTrials.gov registry record

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

A clinical trial of Coronary Microvascular Dysfunction and ST Elevation Myocardial Infarction, sponsored by The Cleveland Clinic.

Recruiting
Registry status
70
Enrollment target
1
Study location

NCT06795035 is a study of Coronary Microvascular Dysfunction and ST Elevation Myocardial Infarction that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 70 participants, below the 262-participant average among 7 other Coronary Microvascular Dysfunction trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06795035, a study of Coronary Microvascular Dysfunction and ST Elevation Myocardial Infarction, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study to measure the heart's microvascular function in the setting of a myocardial infarction (MI), or heart attack, using a method called continuous saline thermodilution (CST). The participants will include people who are experiencing MI from sudden and complete blockage of a coronary artery requiring immediate balloon and/or stent therapy. After getting the balloon and/or stent therapy, participants will have their heart's microvascular system tested using CST. The main questions it aims to answer are: * What measurements using CST can we expect from the heart's microvascular system during a treated MI? * Can CST measurements during a treated MI predict the amount of heart muscle that is injured and that recovers? For this study, participants will undergo measurement of their heart's microvascular function after balloon and/or stent therapy for the MI. They will then receive an MRI scan of the heart several days after the MI.

Conditions Studied

Coronary Microvascular Dysfunction ST Elevation Myocardial Infarction Microvascular Obstruction

Interventions

  • DIAGNOSTIC_TEST Continuous Saline Thermodilution

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-05-29
Est. Completion 2027-12-31

Sponsor

The Cleveland Clinic

688 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06795035

The ClinicalTrials.gov registry entry for NCT06795035 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 7 other Coronary Microvascular Dysfunction trials with a reported enrollment target (73% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Coronary Microvascular Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Continuous Saline Thermodilution is the first listed.

NCT06795035 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06795035 about?

NCT06795035 is a clinical study titled "Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution". The goal of this observational study to measure the heart's microvascular function in the setting of a myocardial infarction (MI), or heart attack, using a method called continuous saline thermodilution (CST). The participants will include people who are experiencing MI from sudden and complete bloc...

What is the current status of trial NCT06795035?

This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2025-05-29. Estimated completion is 2027-12-31.

What conditions does trial NCT06795035 study?

This clinical trial studies the following conditions: Coronary Microvascular Dysfunction, ST Elevation Myocardial Infarction, Microvascular Obstruction.

What interventions are being tested in trial NCT06795035?

The interventions under investigation include: Continuous Saline Thermodilution (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06795035?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06795035 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Microvascular Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Microvascular Dysfunction

All registered trials for this condition

ST Elevation Myocardial Infarction

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.